Prevention of delayed ischemic deficits after aneurysmal subarachnoid hemorrhage by intrathecal bolus injection of tissue plasminogen activator


Phase N/A Results


Delayed ischemic deficits, attributable to the occurrence of vasospasm were apparent in 8% of the rtPA treated patients and 23.5% of control group patients. This difference was statistically significant.